Article(id=1325223559785742529, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.06.002, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1766851200000, receivedDateStr=2025-12-28, revisedDate=1776787200000, revisedDateStr=2026-04-22, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887518116, onlineDateStr=2026-11-05, pubDate=1781020800000, pubDateStr=2026-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887518116, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887518116, creator=13701087609, updateTime=1793887518116, updator=13701087609, issue=Issue{id=1325223559286620353, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='6', pageStart='589', pageEnd='708', issueExtLink='null', onlineDate='null', pubDate='1781020800000', pubDateStr='2026-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887517997, creator='13701087609', updateTime=1793934768161, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421740901413504, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421740901413505, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223559286620353, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=595, endPage=600, ext={EN=ArticleExt(id=1325223560062566594, articleId=1325223559785742529, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Clinical research progress of complement inhibitors in nephrotic syndrome, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Nephrotic syndrome(NS) is a group of clinical syndromes characterized by massive proteinuria and complicated pathogenesis, and its treatment strategies urgently require a breakthrough. In recent years, abnormal activation of the complement system has been confirmed as a key link leading to damage to the glomerular filtration barrier, and targeted therapy against specific complement components has become a cutting-edge research direction in nephrology. This review focuses on the core role of complement component 5a and its receptor axis, mannan-binding lectin serine protease 2 of the lectin pathway, and the alternative pathway in driving NS progression, summarizes the clinical advances of related pathway inhibitors, and discusses their therapeutic potential, the available evidence, and future research directions.

, authors=Liang ZHANG1, Wei ZHANG1, *, Niansong WANG2, *, authorsList=Liang ZHANG, Wei ZHANG, Niansong WANG, authorCompany=null, correspAuthors=Wei ZHANG, Niansong WANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223560351973571, articleId=1325223559785742529, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=补体抑制剂在肾病综合征中的临床研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

肾病综合征(nephrotic syndrome,NS)是一组以大量蛋白尿为核心的临床综合征,发病机制复杂,治疗策略亟待突破。近年来,补体系统的异常激活被证实为导致肾小球滤过屏障损伤的关键环节,针对特定补体成分的靶向治疗已成为肾病领域最前沿的研究方向。现聚焦于补体成分5a及其受体轴、凝集素途径的甘露聚糖结合凝集素丝氨酸蛋白酶2及替代通路在驱动NS进展中的核心作用,综述相关通路抑制剂临床进展,探讨其治疗潜力、现有证据及未来研究方向。

, authors=张良1, 张玮1, *, 汪年松2, *, authorsList=张良, 张玮, 汪年松, authorCompany=null, correspAuthors=张玮, 汪年松, authorNote=

张良,主治医师,研究方向:肾脏疾病诊治。

, correspAuthorsNote=
张玮,主任医师,研究方向:糖尿病肾病、慢性肾脏病等各类肾脏疾病中西医结合诊疗
汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤的发病机制和防治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=Inm+NxZz/UiKYLssGA55oA==, magXml=u51DjD1UiJB7AnfbP5Byew==, pdfUrl=null, pdf=Jby31IsNpaESFG2Z9IlbnA==, pdfFileSize=941503, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ww5ZrpT2obB48/jR4ouE4w==, mapNumber=null, fund=null)}, authors=[Author(id=1325223560846901451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223560960147661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223560846901451, language=EN, stringName=Liang ZHANG, firstName=Liang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561044033742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223560846901451, language=CN, stringName=张良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市杨浦区中医医院肾病科,上海 200090, bio={"content":"

张良,主治医师,研究方向:肾脏疾病诊治。

"}, bioImg=null, bioContent=

张良,主治医师,研究方向:肾脏疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560612020420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=1., ext=[AuthorCompanyExt(id=1325223560620409029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1325223560628797638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市杨浦区中医医院肾病科,上海 200090)])]), Author(id=1325223561136308432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223561245360338, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561136308432, language=EN, stringName=Wei ZHANG, firstName=Wei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561325052115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561136308432, language=CN, stringName=张玮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市杨浦区中医医院肾病科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560612020420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=1., ext=[AuthorCompanyExt(id=1325223560620409029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1325223560628797638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市杨浦区中医医院肾病科,上海 200090)])]), Author(id=1325223561425715413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223561555738839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561425715413, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561648013528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561425715413, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560725266631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=2., ext=[AuthorCompanyExt(id=1325223560733655240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223560742043849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])])], keywords=[Keyword(id=1325223561761259737, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=EN, orderNo=1, keyword=complement system), Keyword(id=1325223561857728730, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=EN, orderNo=2, keyword=complement component 5a), Keyword(id=1325223561945809115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=EN, orderNo=3, keyword=mannose-binding lectin-associated serine protease 2), Keyword(id=1325223562042278108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=EN, orderNo=4, keyword=alternative pathway), Keyword(id=1325223562138747101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=EN, orderNo=5, keyword=nephrotic syndrome), Keyword(id=1325223562226827486, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=CN, orderNo=1, keyword=补体系统), Keyword(id=1325223562319102175, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=CN, orderNo=2, keyword=补体成分5a), Keyword(id=1325223562419765472, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=CN, orderNo=3, keyword=甘露糖结合凝集素相关丝氨酸蛋白酶2), Keyword(id=1325223562549788897, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=CN, orderNo=4, keyword=替代通路), Keyword(id=1325223562650452194, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, language=CN, orderNo=5, keyword=肾病综合征)], refs=[Reference(id=1325223565007651049, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=王海燕. 肾脏病学[M]. 北京: 人民卫生出版社, 2008: 1380., articleTitle=null, refAbstract=null), Reference(id=1325223565095731434, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=JENNETTE JC, FALK RJ, NACHMAN PH. Brenner&rector's the kidney[M]. 9th ed. Philadelphia: Saunders, 2012: 1221., articleTitle=null, refAbstract=null), Reference(id=1325223565208977643, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=TSAI IJ, LIN WC, YANG YH, et al. High concentration of C5a-induced mitochondria-dependent apoptosis in murine kidney endothelial cells[J]. Int J Mol Sci, 2019, 20(18):4465., articleTitle=null, refAbstract=null), Reference(id=1325223565347389676, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=YE B, CHEN B, GUO C, et al. C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis[J]. Mol Ther, 2024, 32(5): 1540-1560., articleTitle=null, refAbstract=null), Reference(id=1325223565431275757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=GONG XJ, HUANG J, SHU Y, et al. Complement C5a and C5a receptor 1 mediates glomerular damage in focal segmental glomerulosclerosis[J]. Clin Immunol, 2025, 273:110459., articleTitle=null, refAbstract=null), Reference(id=1325223565519356142, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, YAN X, ZHAO T, et al. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice[J]. Clin Exp Immunol, 2017, 189(1): 60-70., articleTitle=null, refAbstract=null), Reference(id=1325223565603242223, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU L, ZHANG Y, DUAN X, et al. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy[J]. J Clin Immunol, 2014, 34(2): 224-232., articleTitle=null, refAbstract=null), Reference(id=1325223565703905520, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=BRUCHFELD A, NACHMAN P. PARIKH S, et al. TO012C5A receptor inhibitor avacopan in IgA nephropathy study[J]. Clin Kidney J, 2022, 15(5): 922-928., articleTitle=null, refAbstract=null), Reference(id=1325223565800374513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=JAYNE DR, MERKEL PA, SCHALL TJ. Avacopan for the treatment of ANCA-associated vasculitis[J]. N Engl J Med, 2021, 384(21): e81., articleTitle=null, refAbstract=null), Reference(id=1325223565884260594, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=RING T, PEDERSEN BB, SALKUS G, et al. Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?[J]. Clin Kidney J, 2015, 8(5): 489-491., articleTitle=null, refAbstract=null), Reference(id=1325223565976535283, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAMS CEC, LAMOND M, MARRO J, et al. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis(HSP)[J]. Clin Rheumatol, 2023,42(12): 3189-3200., articleTitle=null, refAbstract=null), Reference(id=1325223566077198580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=JAYNE D. Complement inhibition in ANCA vasculitis[J]. Nephrol Ther, 2019, 15(6): 409-412., articleTitle=null, refAbstract=null), Reference(id=1325223566198833397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=ROSENBLAD T, REBETZ J, JOHANSSON M, et al. Eculizumab treatment for rescue of renal function in IgA nephropathy[J]. Pediatr Nephrol, 2014, 29(11): 2225-2228., articleTitle=null, refAbstract=null), Reference(id=1325223566320468214, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=HERZOG A, WANNER C, AMANN K, et al. First treatment of relapsing rapidly progressive IgA nephropathy with eculizumab after living kidney donation: a case report[J]. Transplant Proc, 2017, 49(7): 1574-1577., articleTitle=null, refAbstract=null), Reference(id=1325223566416937207, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=RIEDEMANN NC, HABEL M, ZIEREISEN J, et al. Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition[J]. Clin Immunol, 2017, 180:25-32., articleTitle=null, refAbstract=null), Reference(id=1325223566513406200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MEDJERAL-THOMAS NR, TROLDBORG A, CONSTANTINOU N, et al. Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3(MASP-3) and increased glomerular factor H–related protein-5(FHR5) deposition[J]. Kidney Int Rep, 2017, 3(2): 426-438., articleTitle=null, refAbstract=null), Reference(id=1325223566597292281, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=POPPELAARS F, FARIA B, SCHWAEBLE W, et al. The contribution of complement to the pathogenesis of IgA nephropathy: are complement-targeted therapies moving from rare disorders to more common diseases?[J]. J Clin Med, 2021, 10(20): 4715., articleTitle=null, refAbstract=null), Reference(id=1325223566676984059, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=GARRED P, GENSTER N, PILELY K, et al. A journey through the lectin pathway of complement-MBL and beyond[J]. Immunol Rev, 2016, 274(1): 74-97., articleTitle=null, refAbstract=null), Reference(id=1325223566752481532, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=KUSAKARI K, MACHIDA T, ISHIDA Y, et al. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation[J]. Front Immunol, 2022, 13: 907023., articleTitle=null, refAbstract=null), Reference(id=1325223566832173309, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=DUDLER T, YASEEN S, CUMMINGS WJ. Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders[J]. Front Immunol, 2023, 14: 1297352., articleTitle=null, refAbstract=null), Reference(id=1325223566916059390, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=BARRATT J, LAFAYETTE RA, FLOEGE J. Therapy of IgA nephropathy: time for a paradigm change[J]. Front Med(Lausanne), 2024, 11: 1461879., articleTitle=null, refAbstract=null), Reference(id=1325223567008334079, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=LAFAYETTE RA, ROVIN BH, REICH HN, et al. Safety, tolerability and efficacy of narsoplimab, a novel MASP-2 inhibitor for the treatment of IgA nephropathy[J]. Kidney Int Rep, 2020, 5(11): 2032-2041., articleTitle=null, refAbstract=null), Reference(id=1325223567083831552, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=BELCHER JD, NGUYEN J, CHEN C, et al. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease[J]. Transl Res, 2022,249: 1-12., articleTitle=null, refAbstract=null), Reference(id=1325223567171911937, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=SZAKACS D, KOCSIS A, SZASZ R, et al. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors[J]. J Biol Chem, 2019,294(20): 8227-8237., articleTitle=null, refAbstract=null), Reference(id=1325223567272575234, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=NAKHLA MC, COMITA J, SHAPIRO AB, et al. Small molecule inhibitors of mannan-binding lectin-associated serine proteases-2 and-3[J]. Eur J Med Chem, 2025, 289:117238., articleTitle=null, refAbstract=null), Reference(id=1325223567390015747, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=KOCSIS A, BARTUS D, HIRSCH E, et al. SARS-CoV-2 nucleocapsid protein is not responsible for over-activation of complement lectin pathway[J]. Int J Mol Sci, 2024, 25(13):7343., articleTitle=null, refAbstract=null), Reference(id=1325223567499067652, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=ROQUIGNY J, MEULEMAN MS, EL SISSY C, et al. Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN[J]. Nephrol Dial Transplant, 2025, 40(6):1081-1090., articleTitle=null, refAbstract=null), Reference(id=1325223569176789253, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=ZANCHI C, LOCATELLI M, CORNA D, et al. Liver factor B silencing to cure C3 glomerulopathy: evidence from a mouse model of complement dysregulation[J]. Mol Immunol, 2023,161: 25-32., articleTitle=null, refAbstract=null), Reference(id=1325223569281646854, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=DONADELLI R, PULIERI P, PIRAS R, et al. Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN[J]. Front Immunol, 2018, 9: 2329., articleTitle=null, refAbstract=null), Reference(id=1325223569373921543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=LUO W, OLARU F, MINER JH, et al. Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy[J]. Front Immunol, 2018, 9: 1433., articleTitle=null, refAbstract=null), Reference(id=1325223569503944968, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=MORIGI M, LOCATELLI M, ROTA C, et al. A previously unrecognized role of C3a in proteinuric progressive nephropathy[J]. Sci Rep, 2016, 6: 28445., articleTitle=null, refAbstract=null), Reference(id=1325223569583636745, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=ZANCHI C, LOCATELLI M, CERULLO D, et al. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy[J]. Mol Immunol, 2024, 168: 10-16., articleTitle=null, refAbstract=null), Reference(id=1325223569663328522, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=GOLOMINGI M, KOHLER J, LAMERS C, et al. Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels[J]. Front Immunol, 2023, 14: 1226832., articleTitle=null, refAbstract=null), Reference(id=1325223569763991819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=WILLIAMS AL, GULLIPALLI D, UEDA Y, et al. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy[J]. Kidney Int, 2017, 91(6): 1386-1397., articleTitle=null, refAbstract=null), Reference(id=1325223569856266508, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=ISPASANIE E, MURI L, SCHMID M, et al. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway[J]. Front Immunol, 2023, 14: 1180833., articleTitle=null, refAbstract=null), Reference(id=1325223569977901325, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=MURI L, SCHUBART A, THORBURN C, et al. Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b[J]. Front Immunol, 2022, 13: 1020580., articleTitle=null, refAbstract=null)], funds=[Fund(id=1325223562788864227, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=82270761, language=CN, fundingSource=国家自然基金面上项目(82270761), fundOrder=null, country=null), Fund(id=1325223562881138916, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=2023YFC2411803, language=CN, fundingSource=国家重点研发计划(2023YFC2411803), fundOrder=null, country=null), Fund(id=1325223563015356645, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=2022ZZ01002(3), language=CN, fundingSource=上海市重中之重研究中心建设项目(2022ZZ01002(3)), fundOrder=null, country=null), Fund(id=1325223564709855462, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=ZY(2021-2023)-0205-04, language=CN, fundingSource=上海市进一步加快中医药传承创新发展三年行动计划(ZY(2021-2023)-0205-04), fundOrder=null, country=null), Fund(id=1325223564797935847, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=240117, language=CN, fundingSource=上海市杨浦区卫健系统“好医师”建设工程(240117), fundOrder=null, country=null), Fund(id=1325223564890210536, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, awardId=YPZYQ202308, language=CN, fundingSource=杨浦区卫生健康委员会中医专项科研课题计划(YPZYQ202308), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1325223560612020420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=1., ext=[AuthorCompanyExt(id=1325223560620409029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1325223560628797638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市杨浦区中医医院肾病科,上海 200090)]), AuthorCompany(id=1325223560725266631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=2., ext=[AuthorCompanyExt(id=1325223560733655240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223560742043849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.06.002, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.06.002, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.06.002, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.06.002, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1781020800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
补体抑制剂在肾病综合征中的临床研究进展
张良 1 , 张玮 1, * , 汪年松 2, *
世界临床药物 | 医药专论 2026,47(6): 595-600
收起
收藏切换
世界临床药物 |医药专论 2026 , 47 (6) : 595 -600
补体抑制剂在肾病综合征中的临床研究进展
全屏
[Author(id=1325223560846901451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223560960147661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223560846901451, language=EN, stringName=Liang ZHANG, firstName=Liang, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561044033742, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223560846901451, language=CN, stringName=张良, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.上海市杨浦区中医医院肾病科,上海 200090, bio={"content":"

张良,主治医师,研究方向:肾脏疾病诊治。

"}, bioImg=null, bioContent=

张良,主治医师,研究方向:肾脏疾病诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560612020420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=1., ext=[AuthorCompanyExt(id=1325223560620409029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1325223560628797638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市杨浦区中医医院肾病科,上海 200090)])]), Author(id=1325223561136308432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223561245360338, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561136308432, language=EN, stringName=Wei ZHANG, firstName=Wei, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561325052115, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561136308432, language=CN, stringName=张玮, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.上海市杨浦区中医医院肾病科,上海 200090, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560612020420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=1., ext=[AuthorCompanyExt(id=1325223560620409029, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China), AuthorCompanyExt(id=1325223560628797638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560612020420, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.上海市杨浦区中医医院肾病科,上海 200090)])]), Author(id=1325223561425715413, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223561555738839, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561425715413, language=EN, stringName=Niansong WANG, firstName=Niansong, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223561648013528, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, authorId=1325223561425715413, language=CN, stringName=汪年松, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223560725266631, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, xref=2., ext=[AuthorCompanyExt(id=1325223560733655240, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China), AuthorCompanyExt(id=1325223560742043849, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223559785742529, companyId=1325223560725266631, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海交通大学医学院附属第六人民医院肾内科,上海 200233)])])]
张良1, 张玮1, *, 汪年松2, *
作者信息
  • 1.上海市杨浦区中医医院肾病科,上海 200090
  • 2.上海交通大学医学院附属第六人民医院肾内科,上海 200233
通讯作者:
张玮,主任医师,研究方向:糖尿病肾病、慢性肾脏病等各类肾脏疾病中西医结合诊疗
汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤的发病机制和防治。
作者简介:

张良,主治医师,研究方向:肾脏疾病诊治。

Clinical research progress of complement inhibitors in nephrotic syndrome
Liang ZHANG1, Wei ZHANG1, *, Niansong WANG2, *
Affiliations
  • 1.Department of Nephrology, Yangpu District Hospital of Traditional Chinese Medicine, Shanghai 200090, China
  • 2.Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China
出版时间: 2026-06-10 doi: 10.13683/j.wph.2026.06.002
文章导航
收藏切换

肾病综合征(nephrotic syndrome,NS)是一组以大量蛋白尿为核心的临床综合征,发病机制复杂,治疗策略亟待突破。近年来,补体系统的异常激活被证实为导致肾小球滤过屏障损伤的关键环节,针对特定补体成分的靶向治疗已成为肾病领域最前沿的研究方向。现聚焦于补体成分5a及其受体轴、凝集素途径的甘露聚糖结合凝集素丝氨酸蛋白酶2及替代通路在驱动NS进展中的核心作用,综述相关通路抑制剂临床进展,探讨其治疗潜力、现有证据及未来研究方向。

补体系统  /  补体成分5a  /  甘露糖结合凝集素相关丝氨酸蛋白酶2  /  替代通路  /  肾病综合征

Nephrotic syndrome(NS) is a group of clinical syndromes characterized by massive proteinuria and complicated pathogenesis, and its treatment strategies urgently require a breakthrough. In recent years, abnormal activation of the complement system has been confirmed as a key link leading to damage to the glomerular filtration barrier, and targeted therapy against specific complement components has become a cutting-edge research direction in nephrology. This review focuses on the core role of complement component 5a and its receptor axis, mannan-binding lectin serine protease 2 of the lectin pathway, and the alternative pathway in driving NS progression, summarizes the clinical advances of related pathway inhibitors, and discusses their therapeutic potential, the available evidence, and future research directions.

complement system  /  complement component 5a  /  mannose-binding lectin-associated serine protease 2  /  alternative pathway  /  nephrotic syndrome
张良, 张玮, 汪年松. 补体抑制剂在肾病综合征中的临床研究进展. 世界临床药物, 2026 , 47 (6) : 595 -600 . DOI: 10.13683/j.wph.2026.06.002
Liang ZHANG, Wei ZHANG, Niansong WANG. Clinical research progress of complement inhibitors in nephrotic syndrome[J]. World Clinical Drug, 2026 , 47 (6) : 595 -600 . DOI: 10.13683/j.wph.2026.06.002
  • 国家自然基金面上项目(82270761)
  • 国家重点研发计划(2023YFC2411803)
  • 上海市重中之重研究中心建设项目(2022ZZ01002(3))
  • 上海市进一步加快中医药传承创新发展三年行动计划(ZY(2021-2023)-0205-04)
  • 上海市杨浦区卫健系统“好医师”建设工程(240117)
  • 杨浦区卫生健康委员会中医专项科研课题计划(YPZYQ202308)
参考文献 引证文献
排序方式:
[1]
王海燕. 肾脏病学[M]. 北京: 人民卫生出版社, 2008: 1380.
[2]
JENNETTE JC, FALK RJ, NACHMAN PH. Brenner&rector's the kidney[M]. 9th ed. Philadelphia: Saunders, 2012: 1221.
[3]
TSAI IJ, LIN WC, YANG YH, et al. High concentration of C5a-induced mitochondria-dependent apoptosis in murine kidney endothelial cells[J]. Int J Mol Sci, 2019, 20(18):4465.
[4]
YE B, CHEN B, GUO C, et al. C5a-C5aR1 axis controls mitochondrial fission to promote podocyte injury in lupus nephritis[J]. Mol Ther, 2024, 32(5): 1540-1560.
[5]
GONG XJ, HUANG J, SHU Y, et al. Complement C5a and C5a receptor 1 mediates glomerular damage in focal segmental glomerulosclerosis[J]. Clin Immunol, 2025, 273:110459.
[6]
ZHANG Y, YAN X, ZHAO T, et al. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice[J]. Clin Exp Immunol, 2017, 189(1): 60-70.
[7]
LIU L, ZHANG Y, DUAN X, et al. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy[J]. J Clin Immunol, 2014, 34(2): 224-232.
[8]
BRUCHFELD A, NACHMAN P. PARIKH S, et al. TO012C5A receptor inhibitor avacopan in IgA nephropathy study[J]. Clin Kidney J, 2022, 15(5): 922-928.
[9]
JAYNE DR, MERKEL PA, SCHALL TJ. Avacopan for the treatment of ANCA-associated vasculitis[J]. N Engl J Med, 2021, 384(21): e81.
[10]
RING T, PEDERSEN BB, SALKUS G, et al. Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?[J]. Clin Kidney J, 2015, 8(5): 489-491.
[11]
WILLIAMS CEC, LAMOND M, MARRO J, et al. A narrative review of potential drug treatments for nephritis in children with IgA vasculitis(HSP)[J]. Clin Rheumatol, 2023,42(12): 3189-3200.
[12]
JAYNE D. Complement inhibition in ANCA vasculitis[J]. Nephrol Ther, 2019, 15(6): 409-412.
[13]
ROSENBLAD T, REBETZ J, JOHANSSON M, et al. Eculizumab treatment for rescue of renal function in IgA nephropathy[J]. Pediatr Nephrol, 2014, 29(11): 2225-2228.
[14]
HERZOG A, WANNER C, AMANN K, et al. First treatment of relapsing rapidly progressive IgA nephropathy with eculizumab after living kidney donation: a case report[J]. Transplant Proc, 2017, 49(7): 1574-1577.
[15]
RIEDEMANN NC, HABEL M, ZIEREISEN J, et al. Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition[J]. Clin Immunol, 2017, 180:25-32.
[16]
MEDJERAL-THOMAS NR, TROLDBORG A, CONSTANTINOU N, et al. Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3(MASP-3) and increased glomerular factor H–related protein-5(FHR5) deposition[J]. Kidney Int Rep, 2017, 3(2): 426-438.
[17]
POPPELAARS F, FARIA B, SCHWAEBLE W, et al. The contribution of complement to the pathogenesis of IgA nephropathy: are complement-targeted therapies moving from rare disorders to more common diseases?[J]. J Clin Med, 2021, 10(20): 4715.
[18]
GARRED P, GENSTER N, PILELY K, et al. A journey through the lectin pathway of complement-MBL and beyond[J]. Immunol Rev, 2016, 274(1): 74-97.
[19]
KUSAKARI K, MACHIDA T, ISHIDA Y, et al. The complex formation of MASP-3 with pattern recognition molecules of the lectin complement pathway retains MASP-3 in the circulation[J]. Front Immunol, 2022, 13: 907023.
[20]
DUDLER T, YASEEN S, CUMMINGS WJ. Development and characterization of narsoplimab, a selective MASP-2 inhibitor, for the treatment of lectin-pathway-mediated disorders[J]. Front Immunol, 2023, 14: 1297352.
[21]
BARRATT J, LAFAYETTE RA, FLOEGE J. Therapy of IgA nephropathy: time for a paradigm change[J]. Front Med(Lausanne), 2024, 11: 1461879.
[22]
LAFAYETTE RA, ROVIN BH, REICH HN, et al. Safety, tolerability and efficacy of narsoplimab, a novel MASP-2 inhibitor for the treatment of IgA nephropathy[J]. Kidney Int Rep, 2020, 5(11): 2032-2041.
[23]
BELCHER JD, NGUYEN J, CHEN C, et al. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease[J]. Transl Res, 2022,249: 1-12.
[24]
SZAKACS D, KOCSIS A, SZASZ R, et al. Novel MASP-2 inhibitors developed via directed evolution of human TFPI1 are potent lectin pathway inhibitors[J]. J Biol Chem, 2019,294(20): 8227-8237.
[25]
NAKHLA MC, COMITA J, SHAPIRO AB, et al. Small molecule inhibitors of mannan-binding lectin-associated serine proteases-2 and-3[J]. Eur J Med Chem, 2025, 289:117238.
[26]
KOCSIS A, BARTUS D, HIRSCH E, et al. SARS-CoV-2 nucleocapsid protein is not responsible for over-activation of complement lectin pathway[J]. Int J Mol Sci, 2024, 25(13):7343.
[27]
ROQUIGNY J, MEULEMAN MS, EL SISSY C, et al. Acquired and genetic drivers of C3 and C5 convertase dysregulation in C3 glomerulopathy and immunoglobulin-associated MPGN[J]. Nephrol Dial Transplant, 2025, 40(6):1081-1090.
[28]
ZANCHI C, LOCATELLI M, CORNA D, et al. Liver factor B silencing to cure C3 glomerulopathy: evidence from a mouse model of complement dysregulation[J]. Mol Immunol, 2023,161: 25-32.
[29]
DONADELLI R, PULIERI P, PIRAS R, et al. Unraveling the molecular mechanisms underlying complement dysregulation by nephritic factors in C3G and IC-MPGN[J]. Front Immunol, 2018, 9: 2329.
[30]
LUO W, OLARU F, MINER JH, et al. Alternative pathway is essential for glomerular complement activation and proteinuria in a mouse model of membranous nephropathy[J]. Front Immunol, 2018, 9: 1433.
[31]
MORIGI M, LOCATELLI M, ROTA C, et al. A previously unrecognized role of C3a in proteinuric progressive nephropathy[J]. Sci Rep, 2016, 6: 28445.
[32]
ZANCHI C, LOCATELLI M, CERULLO D, et al. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy[J]. Mol Immunol, 2024, 168: 10-16.
[33]
GOLOMINGI M, KOHLER J, LAMERS C, et al. Complement inhibition can decrease the haemostatic response in a microvascular bleeding model at multiple levels[J]. Front Immunol, 2023, 14: 1226832.
[34]
WILLIAMS AL, GULLIPALLI D, UEDA Y, et al. C5 inhibition prevents renal failure in a mouse model of lethal C3 glomerulopathy[J]. Kidney Int, 2017, 91(6): 1386-1397.
[35]
ISPASANIE E, MURI L, SCHMID M, et al. In vaccinated individuals serum bactericidal activity against B meningococci is abrogated by C5 inhibition but not by inhibition of the alternative complement pathway[J]. Front Immunol, 2023, 14: 1180833.
[36]
MURI L, SCHUBART A, THORBURN C, et al. Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b[J]. Front Immunol, 2022, 13: 1020580.
2026年第47卷第6期
62
14
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.06.002
  • 接收时间:2025-12-28
  • 首发时间:2026-11-05
  • 出版时间:2026-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-12-28
  • 修回日期:2026-04-22
基金
国家自然基金面上项目(82270761)
国家重点研发计划(2023YFC2411803)
上海市重中之重研究中心建设项目(2022ZZ01002(3))
上海市进一步加快中医药传承创新发展三年行动计划(ZY(2021-2023)-0205-04)
上海市杨浦区卫健系统“好医师”建设工程(240117)
杨浦区卫生健康委员会中医专项科研课题计划(YPZYQ202308)
作者信息
    1.上海市杨浦区中医医院肾病科,上海 200090
    2.上海交通大学医学院附属第六人民医院肾内科,上海 200233

通讯作者:

张玮,主任医师,研究方向:糖尿病肾病、慢性肾脏病等各类肾脏疾病中西医结合诊疗
汪年松,教授,主任医师,研究方向:糖尿病肾病、急性肾损伤的发病机制和防治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.06.002
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏